The trademark OMYCOL was filed by LABORATORIOS SALVAT, S.A., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on April 19, 2022, and received one opposition filed on July 4, 2022 by ACTA FARMA, S.L. on Likelihood of confusion. the opponent was represented by SUGRAÑES, S.L.P.
It was designated 'Basic Application' for International Application 1669965 at the World Intellectual Property Organization (WIPO).
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on March 28, 2023.
The Appeal with reference B R1638/2023-5 was Application rejected according to Article 8(1)(b) EUTMR with decision issued on March 11, 2024 by the EUIPO. The Opposition with reference B 003174179 was refused according to Article 8(1)(b) EUTMR with decision issued on June 18, 2023 by the EUIPO. The null with reference B T-264/24 was Closed without judgment according to null with decision issued on September 18, 2024 by the EUIPO.
The application claimed as seniority of the Kingdom of Spain trademark M4083122 registered on April 21, 2021 and filed on September 6, 2020 which was accepted by the office.